The LXR–Idol Axis Differentially Regulates Plasma LDL Levels in Primates and Mice
- 1 November 2014
- journal article
- Published by Elsevier in Cell Metabolism
- Vol. 20 (5) , 910-918
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- IDOL Stimulates Clathrin-Independent Endocytosis and Multivesicular Body-Mediated Lysosomal Degradation of the Low-Density Lipoprotein ReceptorMolecular and Cellular Biology, 2013
- TricycloDNA-modified oligo-2′-deoxyribonucleotides reduce scavenger receptor B1 mRNA in hepatic and extra-hepatic tissues—a comparative study of oligonucleotide length, design and chemistryNucleic Acids Research, 2012
- FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptorsProceedings of the National Academy of Sciences, 2011
- The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humansJournal of Clinical Investigation, 2011
- The IDOL–UBE2D complex mediates sterol-dependent degradation of the LDL receptorGenes & Development, 2011
- Targeted Disruption of the Idol Gene Alters Cellular Regulation of the Low-Density Lipoprotein Receptor by Sterols and Liver X Receptor AgonistsMolecular and Cellular Biology, 2011
- Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct targetJournal of Lipid Research, 2011
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL ReceptorScience, 2009
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003